{"id":182547,"date":"2025-09-30T07:28:18","date_gmt":"2025-09-30T06:28:18","guid":{"rendered":"https:\/\/helloproject.es\/vigilancia\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\/"},"modified":"2025-09-30T07:28:18","modified_gmt":"2025-09-30T06:28:18","slug":"una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades","status":"publish","type":"post","link":"https:\/\/helloproject.es\/vigilancia\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\/","title":{"rendered":"Una t\u00e9cnica acelera el desarrollo de f\u00e1rmacos contra prote\u00ednas clave en m\u00faltiples enfermedades"},"content":{"rendered":"<p>Un equipo internacional con participaci\u00f3n del CSIC ha desarrollado una t\u00e9cnica que acelera el dise\u00f1o de f\u00e1rmacos dirigidos a canales i\u00f3nicos, un tipo de prote\u00ednas de la membrana celular implicadas en patolog\u00edas que van desde des\u00f3rdenes psiqui\u00e1tricos hasta varios tipos de c\u00e1ncer.<\/p>\n<p>La investigaci\u00f3n, en la que tambi\u00e9n colaboran la Universidad de East Anglia y el Quadram Institute (Reino Unido), se publica en Journal of the American Chemical Society.<\/p>\n<p>Los canales i\u00f3nicos regulan funciones celulares clave y son dianas terap\u00e9uticas en m\u00faltiples enfermedades<\/p>\n<p>Los canales i\u00f3nicos regulan el paso de iones hacia el interior de la c\u00e9lula y son esenciales en procesos como la\u00a0transmisi\u00f3n nerviosa, la contracci\u00f3n muscular o la respuesta inmunitaria\u00a0Su mal funcionamiento se asocia con numerosas enfermedades, lo que los convierte en dianas terap\u00e9uticas prioritarias.<\/p>\n<p><a><\/a><\/p>\n<h2>Estudio en c\u00e9lulas vivas<\/h2>\n<p>\u201cHasta ahora, para estudiar c\u00f3mo los f\u00e1rmacos interaccionaban con estas prote\u00ednas era necesario aislarlas, un proceso t\u00e9cnicamente complejo que pod\u00eda alterar su comportamiento\u201d, explica Jes\u00fas Angulo, investigador del Instituto de Investigaciones Qu\u00edmicas (CSIC-Universidad de Sevilla).<\/p>\n<p>Seg\u00fan Angulo, \u201cla nueva t\u00e9cnica, basada en resonancia magn\u00e9tica nuclear, permite estudiarlas en c\u00e9lulas vivas, lo que proporciona informaci\u00f3n biol\u00f3gicamente m\u00e1s relevante\u201d, explica\u00a0<\/p>\n<p>El nuevo m\u00e9todo es m\u00e1s r\u00e1pido \u2014los experimentos duran menos de una hora\u2014, m\u00e1s econ\u00f3mico y m\u00e1s simple, ya que evita la purificaci\u00f3n de prote\u00ednas o la manipulaci\u00f3n compleja de muestras.\u00a0<\/p>\n<p><a><\/a><\/p>\n<h2>Forma qu\u00edmica y efecto farmacol\u00f3gico<\/h2>\n<p>Los autores consideran que podr\u00eda convertirse en una herramienta est\u00e1ndar en los estudios de estructura-actividad, que buscan comprender c\u00f3mo la forma qu\u00edmica de una mol\u00e9cula se relaciona con su efecto farmacol\u00f3gico.<\/p>\n<p>\u201cNuestra t\u00e9cnica podr\u00eda acelerar significativamente el desarrollo de\u00a0f\u00e1rmacos dirigidos a canales i\u00f3nicos y otras prote\u00ednas de membrana, abriendo nuevas posibilidades en \u00e1reas como las enfermedades neurol\u00f3gicas, cardiovasculares, metab\u00f3licas u oncol\u00f3gicas\u201d, se\u00f1ala\u00a0Leanne Stokes, de la Universidad de East Anglia.<\/p>\n<p>El m\u00e9todo se ha probado en los receptores P2X7, dianas terap\u00e9uticas para la depresi\u00f3n, ciertos trastornos del espectro autista y algunos tipos de c\u00e1ncer<\/p>\n<p>El m\u00e9todo se ha probado en los receptores P2X7, dianas terap\u00e9uticas para la depresi\u00f3n, ciertos trastornos del espectro autista y algunos tipos de c\u00e1ncer.<\/p>\n<p>\u201cHemos demostrado que podemos identificar, sobre c\u00e9lulas vivas, qu\u00e9 partes del f\u00e1rmaco interaccionan con la prote\u00edna, lo que permite optimizar estas interacciones; una informaci\u00f3n fundamental para desarrollar medicamentos m\u00e1s efectivos y espec\u00edficos\u201d, afirma Serena Monaco, del Quadram Institute de Norwich.<\/p>\n<p><a><\/a><\/p>\n<h2>Software<\/h2>\n<p>Adem\u00e1s, gracias a un software desarrollado en el IIQ-CSIC-US, los datos obtenidos se combinaron con modelos tridimensionales de uni\u00f3n entre f\u00e1rmaco y receptor generados mediante bioinform\u00e1tica. Esto permiti\u00f3 validar cu\u00e1les coincid\u00edan con los resultados observados en el laboratorio.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.agenciasinc.es\/bundles\/app\/images\/quotebefore.png\" \/><\/p>\n<p>Poder validar los modelos inform\u00e1ticos tridimensionales sobre c\u00e9lulas vivas supone un nuevo paradigma en el desarrollo de f\u00e1rmacos<\/p>\n<p>Jes\u00fas Angulo (Instituto de Investigaciones Qu\u00edmicas)<br \/>\n<img decoding=\"async\" src=\"https:\/\/www.agenciasinc.es\/bundles\/app\/images\/quoteafter.png\" \/><\/p>\n<p>\u201cLa interacci\u00f3n entre f\u00e1rmaco y prote\u00edna puede compararse con una llave y una cerradura. La prote\u00edna de membrana es la cerradura y nuestra llave es el f\u00e1rmaco. No solo hay que encontrar la llave adecuada, sino introducirla de la forma correcta para que abra mejor\u201d, explica Angulo. \u201cPoder validar los modelos inform\u00e1ticos tridimensionales sobre c\u00e9lulas vivas supone un nuevo paradigma en el desarrollo de f\u00e1rmacos\u201d, concluye.<\/p>\n<p>Referencia:<\/p>\n<p>Monaco, S.. et al.\u00a0\u201cOn-Cell Saturation Transfer Difference NMR Spectroscopy on Ion Channels: Characterizing Negative Allosteric Modulator Binding Interactions of P2X7\u201d,. Journal of the American Chemical Society (2025).<\/p>","protected":false},"excerpt":{"rendered":"<p>Un equipo internacional con participaci\u00f3n del CSIC ha desarrollado una t\u00e9cnica que acelera el dise\u00f1o de f\u00e1rmacos dirigidos a canales i\u00f3nicos, un tipo de prote\u00ednas de la membrana celular implicadas en patolog\u00edas que van desde des\u00f3rdenes psiqui\u00e1tricos hasta varios tipos de c\u00e1ncer. La investigaci\u00f3n, en la que tambi\u00e9n colaboran la Universidad de East Anglia y [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[5],"tags":[],"class_list":["post-182547","post","type-post","status-publish","format-standard","hentry","category-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.9 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Una t\u00e9cnica acelera el desarrollo de f\u00e1rmacos contra prote\u00ednas clave en m\u00faltiples enfermedades - bip4ex<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/helloproject.es\/vigilancia\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Una t\u00e9cnica acelera el desarrollo de f\u00e1rmacos contra prote\u00ednas clave en m\u00faltiples enfermedades\" \/>\n<meta property=\"og:description\" content=\"Un equipo internacional con participaci\u00f3n del CSIC ha desarrollado una t\u00e9cnica que acelera el dise\u00f1o de f\u00e1rmacos dirigidos a canales i\u00f3nicos, un tipo de prote\u00ednas de la membrana celular implicadas en patolog\u00edas que van desde des\u00f3rdenes psiqui\u00e1tricos hasta varios tipos de c\u00e1ncer. La investigaci\u00f3n, en la que tambi\u00e9n colaboran la Universidad de East Anglia y [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/helloproject.es\/vigilancia\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\/\" \/>\n<meta property=\"og:site_name\" content=\"bip4ex\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-30T06:28:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.agenciasinc.es\/bundles\/app\/images\/quotebefore.png\" \/>\n<meta name=\"author\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\\\/\"},\"author\":{\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\"},\"headline\":\"Una t\u00e9cnica acelera el desarrollo de f\u00e1rmacos contra prote\u00ednas clave en m\u00faltiples enfermedades\",\"datePublished\":\"2025-09-30T06:28:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\\\/\"},\"wordCount\":657,\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.agenciasinc.es\\\/bundles\\\/app\\\/images\\\/quotebefore.png\",\"articleSection\":[\"Noticias\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\\\/\",\"name\":\"Una t\u00e9cnica acelera el desarrollo de f\u00e1rmacos contra prote\u00ednas clave en m\u00faltiples enfermedades - bip4ex\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.agenciasinc.es\\\/bundles\\\/app\\\/images\\\/quotebefore.png\",\"datePublished\":\"2025-09-30T06:28:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.agenciasinc.es\\\/bundles\\\/app\\\/images\\\/quotebefore.png\",\"contentUrl\":\"https:\\\/\\\/www.agenciasinc.es\\\/bundles\\\/app\\\/images\\\/quotebefore.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Una t\u00e9cnica acelera el desarrollo de f\u00e1rmacos contra prote\u00ednas clave en m\u00faltiples enfermedades\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"name\":\"bip4ex\",\"description\":\"Vigilancia Tecnol\u00f3gica\",\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\",\"name\":\"Helloproject.es\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"contentUrl\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"width\":322,\"height\":365,\"caption\":\"Helloproject.es\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\",\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/author\\\/luismi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Una t\u00e9cnica acelera el desarrollo de f\u00e1rmacos contra prote\u00ednas clave en m\u00faltiples enfermedades - bip4ex","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/helloproject.es\/vigilancia\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\/","og_locale":"es_ES","og_type":"article","og_title":"Una t\u00e9cnica acelera el desarrollo de f\u00e1rmacos contra prote\u00ednas clave en m\u00faltiples enfermedades","og_description":"Un equipo internacional con participaci\u00f3n del CSIC ha desarrollado una t\u00e9cnica que acelera el dise\u00f1o de f\u00e1rmacos dirigidos a canales i\u00f3nicos, un tipo de prote\u00ednas de la membrana celular implicadas en patolog\u00edas que van desde des\u00f3rdenes psiqui\u00e1tricos hasta varios tipos de c\u00e1ncer. La investigaci\u00f3n, en la que tambi\u00e9n colaboran la Universidad de East Anglia y [&hellip;]","og_url":"https:\/\/helloproject.es\/vigilancia\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\/","og_site_name":"bip4ex","article_published_time":"2025-09-30T06:28:18+00:00","og_image":[{"url":"https:\/\/www.agenciasinc.es\/bundles\/app\/images\/quotebefore.png","type":"","width":"","height":""}],"author":"Luis Miguel Mej\u00edas Ramos","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Luis Miguel Mej\u00edas Ramos","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/helloproject.es\/vigilancia\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\/#article","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\/"},"author":{"name":"Luis Miguel Mej\u00edas Ramos","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca"},"headline":"Una t\u00e9cnica acelera el desarrollo de f\u00e1rmacos contra prote\u00ednas clave en m\u00faltiples enfermedades","datePublished":"2025-09-30T06:28:18+00:00","mainEntityOfPage":{"@id":"https:\/\/helloproject.es\/vigilancia\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\/"},"wordCount":657,"publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\/#primaryimage"},"thumbnailUrl":"https:\/\/www.agenciasinc.es\/bundles\/app\/images\/quotebefore.png","articleSection":["Noticias"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/helloproject.es\/vigilancia\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\/","url":"https:\/\/helloproject.es\/vigilancia\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\/","name":"Una t\u00e9cnica acelera el desarrollo de f\u00e1rmacos contra prote\u00ednas clave en m\u00faltiples enfermedades - bip4ex","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/#website"},"primaryImageOfPage":{"@id":"https:\/\/helloproject.es\/vigilancia\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\/#primaryimage"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\/#primaryimage"},"thumbnailUrl":"https:\/\/www.agenciasinc.es\/bundles\/app\/images\/quotebefore.png","datePublished":"2025-09-30T06:28:18+00:00","breadcrumb":{"@id":"https:\/\/helloproject.es\/vigilancia\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/helloproject.es\/vigilancia\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/helloproject.es\/vigilancia\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\/#primaryimage","url":"https:\/\/www.agenciasinc.es\/bundles\/app\/images\/quotebefore.png","contentUrl":"https:\/\/www.agenciasinc.es\/bundles\/app\/images\/quotebefore.png"},{"@type":"BreadcrumbList","@id":"https:\/\/helloproject.es\/vigilancia\/una-tecnica-acelera-el-desarrollo-de-farmacos-contra-proteinas-clave-en-multiples-enfermedades\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/helloproject.es\/vigilancia\/"},{"@type":"ListItem","position":2,"name":"Una t\u00e9cnica acelera el desarrollo de f\u00e1rmacos contra prote\u00ednas clave en m\u00faltiples enfermedades"}]},{"@type":"WebSite","@id":"https:\/\/helloproject.es\/vigilancia\/#website","url":"https:\/\/helloproject.es\/vigilancia\/","name":"bip4ex","description":"Vigilancia Tecnol\u00f3gica","publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/helloproject.es\/vigilancia\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/helloproject.es\/vigilancia\/#organization","name":"Helloproject.es","url":"https:\/\/helloproject.es\/vigilancia\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/","url":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","contentUrl":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","width":322,"height":365,"caption":"Helloproject.es"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca","name":"Luis Miguel Mej\u00edas Ramos","url":"https:\/\/helloproject.es\/vigilancia\/author\/luismi\/"}]}},"_links":{"self":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/182547","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/comments?post=182547"}],"version-history":[{"count":0,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/182547\/revisions"}],"wp:attachment":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/media?parent=182547"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/categories?post=182547"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/tags?post=182547"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}